Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
about
The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.Antimicrobial and antioxidant properties of methanol extract, fractions and compounds from the stem bark of Entada abyssinica Stend ex A. SatabieToxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 miceThe role of apolipoprotein N-acyl transferase, Lnt, in the lipidation of factor H binding protein of Neisseria meningitidis strain MC58 and its potential as a drug target.Comparison of Fluorinated and Nonfluorinated Lipids in Self-Adjuvanting Delivery Systems for Peptide-Based Vaccines.Strategies for intranasal delivery of vaccinesToll-like receptor agonists: a patent review (2011 - 2013).Challenges and solutions for a rational vaccine design for TB-endemic regions.Lipopeptides: from self-assembly to bioactivity.Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2.Particulate matter air pollution from the city of Quito, Ecuador, activates inflammatory signaling pathways in vitro.Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine.Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccines.
P2860
Q30423530-C4107F9E-15A2-4897-A99D-4E9104A2F0D9Q33965469-26334D65-F5A8-4766-9137-07A479F133DBQ35634197-0826C8EC-8A15-4BD5-A3B2-F2CEFB8347D7Q36175206-EFC6C4B0-833C-4144-BAA5-B73AA2B66FBAQ36280591-6B76A154-AE76-4317-8B69-864BB5AE9873Q36514771-05E464CD-9F3C-47D4-A9D6-7BCDEB2CB0DBQ38181176-6D4C2E5C-D01E-4198-9623-FB2CA5ED1A17Q38185119-861757BF-234E-4C50-A93C-18786F7C58ABQ38387028-103CF3B6-3968-4D62-9768-3B4ACF63D74FQ38906815-AC3028A3-2590-4631-AA6A-B9009CC6BAACQ40461125-EF2F0D1C-1BFC-4D8A-8E75-D9B5398CEC2AQ44545446-325AE1C6-A6E4-4B1B-BA94-449CDD2D496DQ55333118-84EEED28-A5DB-4BDF-A119-0A2BC7D9C200
P2860
Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
@en
Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
@nl
type
label
Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
@en
Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
@nl
prefLabel
Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
@en
Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
@nl
P2093
P1433
P1476
Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
@en
P2093
Emily Eriksson
Lara Grollo
Weiguang Zeng
P2860
P2888
P304
P356
10.1007/S00726-009-0463-0
P577
2010-01-21T00:00:00Z
P5875
P6179
1028983998